AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $7,842,000 | +2.8% | 339,638 | -37.2% | 0.02% | -10.7% |
Q3 2020 | $7,632,000 | -56.6% | 540,506 | -53.7% | 0.03% | -20.0% |
Q2 2020 | $17,592,000 | +25.7% | 1,166,518 | -23.0% | 0.04% | 0.0% |
Q1 2020 | $13,990,000 | -51.4% | 1,514,046 | -48.8% | 0.04% | -40.7% |
Q4 2019 | $28,794,000 | +22.9% | 2,956,220 | +1.2% | 0.06% | +25.5% |
Q3 2019 | $23,430,000 | -32.3% | 2,921,424 | +5.3% | 0.05% | -30.9% |
Q2 2019 | $34,616,000 | +84.7% | 2,773,710 | +101.3% | 0.07% | -6.8% |
Q1 2019 | $18,740,000 | +60.5% | 1,377,926 | +13.1% | 0.07% | +43.1% |
Q4 2018 | $11,675,000 | -20.8% | 1,218,691 | 0.0% | 0.05% | -5.6% |
Q3 2018 | $14,734,000 | +64.9% | 1,218,691 | +113.1% | 0.05% | +58.8% |
Q2 2018 | $8,934,000 | +16.1% | 571,952 | +11.8% | 0.03% | +9.7% |
Q1 2018 | $7,693,000 | +3.2% | 511,499 | -1.3% | 0.03% | +6.9% |
Q4 2017 | $7,454,000 | -4.6% | 517,990 | -0.0% | 0.03% | -14.7% |
Q3 2017 | $7,814,000 | -41.5% | 518,172 | -61.0% | 0.03% | -44.3% |
Q2 2017 | $13,368,000 | -13.5% | 1,327,543 | -38.8% | 0.06% | -12.9% |
Q1 2017 | $15,460,000 | +43.5% | 2,168,358 | +0.0% | 0.07% | +37.3% |
Q4 2016 | $10,777,000 | +33.2% | 2,168,322 | +274.9% | 0.05% | +54.5% |
Q3 2015 | $8,091,000 | +3905.4% | 578,343 | +491.7% | 0.03% | +3200.0% |
Q1 2014 | $202,000 | -9.0% | 97,740 | +3.5% | 0.00% | 0.0% |
Q4 2013 | $222,000 | +6.7% | 94,421 | +5.3% | 0.00% | 0.0% |
Q3 2013 | $208,000 | +22.4% | 89,654 | +23.1% | 0.00% | 0.0% |
Q2 2013 | $170,000 | – | 72,832 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |